CHI3L1 and pachyonychia congenita: A composite panel of CA 19-9, OPN, and CHI3L1 was demonstrated to have superior sensitivity for PC compared with CA 19-9 alone (93% vs. 80%), whereas CEA and CA 125 showed prognostic significance for the survival of PC (p < 0.003) when measured simultaneously [43].